Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPO HEXAL vs. ERYPO for anemia in predialysis chronic renal insufficiency
2007-001906-26Phase 3Terminated
- Sponsor
- Hexal AG
- Start
- May 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in anemia of renal disease comparing Epoetin alfa HEXAL with ERYPO (2 arms). Primary endpoints: Immunogenicity and Safety. Started May 2007; status: terminated.
02
Drugs
erythropoietinepoetin alfa
03
Conditions
anemia of renal disease
Beyond the preview
Go deeper on 2007-001906-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001906-26.